Loading...
A Dose Response Study of Thymosin β4 for the Treatment of Acute Stroke
BACKGROUND: Thymosin β4 (Tβ4) is a 5K actin binding peptide. Tβ4 improves neurological outcome in a rat model of embolic stroke and research is now focused on optimizing its dose for clinical trials. The purpose of this study was to perform a dose response study of Tβ4 to determine the optimal dose...
Na minha lista:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2014
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4177939/ https://ncbi.nlm.nih.gov/pubmed/25060418 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jns.2014.07.006 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|